A Pilot Study of a Personalized Neoantigen Cancer Vaccine with and without Low-Dose Cyclophosphamide or Pembrolizumab in Treatment Naïve, Asymptomatic Patients with IGHV Unmutated Chronic Lymphocytic Leukemia.
ENROLLING
Trial ID:
NCT03219450 Protocol # :
17-105
Phase
Feasibility / Pilot
Disease Sites
Myeloid and Monocytic Leukemia
Principal Investigator
Ahn, Inhye
Site Research Nurses
Baylies, Rosemarie
Beaver, Rachel, Maureen
Brennan, Lisa
Burke, Candace
De Marchi, Giuliana
Gillen Mckay, Christine, A.
Kelley, Kristina
Kilcommons, Marykate
Montegaard, JOSIE
Normilus, Samantha
Reyes, Kaitlen, A.
Riley, Emily, L.
Rowan, Jennifer, M.
Stephans, Katherine, F.
Terwilliger, Jamie
Virchick, Barbara
Waisgerber, Susan, M.
Trial Description
Call 877-DF-TRIAL (877-338-7425) to learn more about this clinical trial, protocol #17-105
17-105